Open AccessFeatures of management and vaccination of comorbid patients with rheumatic diseases in a pandemic of a new coronavirus infection
Author(s) -
I. B. Belyaeva,
V. I. Mazurov,
Lyubov E. Sarantseva,
Е. А. Трофимов
Publication year - 2021
Publication title -
rossijskij semejnyj vrač
Language(s) - English
Resource type - Journals
eISSN - 2713-2331
pISSN - 2072-1668
DOI - 10.17816/rfd75815
Subject(s) - medicine , pandemic , rheumatology , vaccination , disease , intensive care medicine , population , diabetes mellitus , covid-19 , coronavirus , obesity , immunology , infectious disease (medical specialty) , environmental health , endocrinology
The review presents the results of scientific studies devoted to the features of the course and outcomes of a new coronavirus infection COVID-19 in patients with immuno-inflammatory rheumatic diseases (IIRD). It was noted that the risk of developing COVID-19 for patients with IVR, apparently, is similar to the population or slightly increased and mostly depends on the presence of established risk factors for its severe course (old age, obesity, diabetes mellitus, cardiovascular diseases). Patients receiving long-term immunosuppressive therapy and high doses of glucocorticoids may have a long period of positive viral replication and isolation of a viable virus, which requires dynamic monitoring of such patients and correction of anti-rheumatic therapy. The issues of post-COVID-19 joint syndrome, which can occur within the framework of post-viral arthritis or be the debut of an immuno-inflammatory rheumatic disease, are highlighted. The draft recommendations of the All-Russian Public Organization Association of Rheumatologists of Russia on the management and temporary recommendations of V.A. Nasonova Research Institute of Rheumatology for vaccination of patients with rheumatic diseases in the conditions of the COVID-19 pandemic are presented.